Archives for June 2019

Introduction To Ufovax & It’s Technology & Products (In Chinese)

June 5, 2019

Cheryl Keech, M.D., Ph.D. has joined Uvax Bio as a Consultant and Acting Chief Medical Officer
Uvax-2129, a recombinant protein nanoparticle vaccine, Uvax Bio’s answer to COVID-19, shows great promise against variants of concern
Reshaping The Vaccine Manufacturing Paradigm
Single-component, self-assembling, protein nanoparticles presenting the receptor binding domain and stabilized spike as SARS-CoV-2 vaccine candidates
Ufovax Extends Its Intellectual Property Portfolio to Include a Patent Covering the Design of an Optimized Antigen For COVID-19

3801 Kennett Pike
Ste. A101, #4482
Wilmington, DE
19807-9998
info@uvaxbio.com